TTK Healthcare Limited (BOM:507747)
881.05
-8.85 (-0.99%)
At close: Jun 16, 2026
TTK Healthcare Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Net Income | 656.81 | 816.57 | 628.42 | 6,397 | 415.88 |
Depreciation & Amortization | 87.6 | 83.28 | 130.22 | 127.57 | 125.16 |
Other Amortization | - | 0.06 | 0.37 | 0.5 | 0.67 |
Loss (Gain) From Sale of Assets | -16.21 | -210.81 | -0.94 | 0.34 | -25.04 |
Asset Writedown & Restructuring Costs | - | 0.01 | 1.2 | - | 0.13 |
Provision & Write-off of Bad Debts | 2.03 | 6.09 | 5.61 | 3.95 | 5.04 |
Other Operating Activities | -615.45 | -703.7 | -660.96 | -6,461 | -368.98 |
Change in Accounts Receivable | -201.69 | -47.8 | 51.45 | -223.03 | -95.85 |
Change in Inventory | -1.29 | -115.99 | -124.75 | 19.1 | -161.21 |
Change in Accounts Payable | -153.62 | 47.75 | -85.49 | -104.05 | 129.29 |
Change in Unearned Revenue | - | - | - | -1.84 | 0.81 |
Change in Other Net Operating Assets | 30.35 | 84.79 | 5.45 | -129.14 | 88.58 |
Operating Cash Flow | -211.48 | -39.76 | -49.43 | -248.11 | 449.96 |
Operating Cash Flow Growth | - | - | - | - | -53.33% |
Capital Expenditures | -58.02 | -128.4 | -103.83 | -116.99 | -55.06 |
Sale of Property, Plant & Equipment | 11.84 | 12.29 | 1.04 | 1.02 | 25.73 |
Investment in Securities | -124.49 | -556.72 | -186.92 | -5,805 | -405.07 |
Other Investing Activities | 686.47 | 873.86 | 574.66 | 6,238 | 138.81 |
Investing Cash Flow | 515.79 | 201.03 | 284.94 | 316.94 | -295.58 |
Short-Term Debt Issued | - | 4.62 | - | 51.44 | 27.86 |
Total Debt Issued | - | 4.62 | - | 51.44 | 27.86 |
Short-Term Debt Repaid | -0.31 | - | -40.55 | - | - |
Long-Term Debt Repaid | -5.63 | -6.21 | -5.84 | -5.48 | -4.6 |
Total Debt Repaid | -5.95 | -6.21 | -46.4 | -5.48 | -4.6 |
Net Debt Issued (Repaid) | -5.95 | -1.59 | -46.4 | 45.96 | 23.26 |
Common Dividends Paid | -141.3 | -141.3 | -141.3 | -141.3 | -84.78 |
Other Financing Activities | -28.31 | -37.91 | -31.41 | -28.92 | -39.76 |
Financing Cash Flow | -175.56 | -180.81 | -219.11 | -124.26 | -101.29 |
Net Cash Flow | 128.75 | -19.53 | 16.39 | -55.44 | 53.09 |
Free Cash Flow | -269.51 | -168.16 | -153.27 | -365.1 | 394.91 |
Free Cash Flow Growth | - | - | - | - | -58.29% |
Free Cash Flow Margin | -3.14% | -2.10% | -2.04% | -5.04% | 6.59% |
Free Cash Flow Per Share | -19.07 | -11.90 | -10.85 | -25.84 | 27.95 |
Cash Interest Paid | 28.31 | 37.91 | 31.41 | 28.92 | 39.76 |
Cash Income Tax Paid | 129.8 | 278.1 | 249.57 | 159.01 | 91.83 |
Levered Free Cash Flow | -3,283 | 31.36 | -11.04 | -493.71 | 120.94 |
Unlevered Free Cash Flow | -3,265 | 43.54 | 1.01 | -460.97 | 141.17 |
Change in Working Capital | -326.25 | -31.25 | -153.34 | -438.96 | -38.39 |